Impax Asset Management Group plc Purchases 663,191 Shares of Xylem Inc. $XYL

Impax Asset Management Group plc boosted its position in shares of Xylem Inc. (NYSE:XYL) by 13.7% in the second quarter, HoldingsChannel.com reports. The fund owned 5,499,688 shares of the industrial products company’s stock after acquiring an additional 663,191 shares during the quarter. Xylem comprises about 4.1% of Impax Asset Management Group plc’s portfolio, making the stock its 3rd largest holding. Impax Asset Management Group plc’s holdings in Xylem were worth $709,183,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. AFG Fiduciary Services Limited Partnership purchased a new position in shares of Xylem during the second quarter worth $275,000. IFM Investors Pty Ltd grew its position in Xylem by 11.6% during the 2nd quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company’s stock worth $6,995,000 after purchasing an additional 5,617 shares during the period. BROOKFIELD Corp ON raised its stake in shares of Xylem by 26.5% during the 1st quarter. BROOKFIELD Corp ON now owns 16,375 shares of the industrial products company’s stock valued at $1,956,000 after buying an additional 3,430 shares during the last quarter. Nordea Investment Management AB lifted its holdings in shares of Xylem by 10.9% in the 2nd quarter. Nordea Investment Management AB now owns 29,826 shares of the industrial products company’s stock valued at $3,830,000 after buying an additional 2,926 shares during the period. Finally, Acadian Asset Management LLC purchased a new stake in shares of Xylem in the second quarter worth about $20,361,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Price Performance

NYSE:XYL opened at $149.68 on Thursday. The stock has a 50 day moving average of $146.02 and a two-hundred day moving average of $136.52. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The firm has a market cap of $36.44 billion, a P/E ratio of 38.48, a price-to-earnings-growth ratio of 2.50 and a beta of 1.15. The company has a current ratio of 1.96, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same period in the previous year, the company posted $1.11 earnings per share. The business’s revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, analysts expect that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Analysts Set New Price Targets

XYL has been the subject of several recent research reports. Argus set a $170.00 price target on Xylem in a research report on Wednesday, October 29th. UBS Group lifted their price objective on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Royal Bank Of Canada increased their target price on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Robert W. Baird set a $178.00 price target on Xylem in a report on Wednesday, October 29th. Finally, Citigroup increased their price target on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $166.90.

Insiders Place Their Bets

In other news, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the transaction, the executive vice president directly owned 31,250 shares in the company, valued at approximately $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,121 shares of company stock valued at $1,982,459 in the last 90 days. 0.27% of the stock is owned by insiders.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.